Cargando…
First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac
The treatment of oligometastatic disease using MR guidance is an evolving field. Since August 2018 patients are treated on a 1.5 Tesla MR-Linac (MRL). We present current workflows and practice standards from seven institutions for the initial patients treated for lymph node and liver metastases.
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108982/ https://www.ncbi.nlm.nih.gov/pubmed/35586786 http://dx.doi.org/10.1016/j.tipsro.2022.04.005 |
_version_ | 1784708820833927168 |
---|---|
author | Janssen, Tomas M. Aitken, Katharine Alongi, Filippo Barry, Aisling Bernchou, Uffe Boeke, Simon Hall, William A. Hosni, Ali Kroon, Petra.S. Nachbar, Marcel Saeed, Hina Jürgenliemk-Schulz, Ina M. Schytte, Tine Verkooijen, Helena M. Nowee, Marlies.E. |
author_facet | Janssen, Tomas M. Aitken, Katharine Alongi, Filippo Barry, Aisling Bernchou, Uffe Boeke, Simon Hall, William A. Hosni, Ali Kroon, Petra.S. Nachbar, Marcel Saeed, Hina Jürgenliemk-Schulz, Ina M. Schytte, Tine Verkooijen, Helena M. Nowee, Marlies.E. |
author_sort | Janssen, Tomas M. |
collection | PubMed |
description | The treatment of oligometastatic disease using MR guidance is an evolving field. Since August 2018 patients are treated on a 1.5 Tesla MR-Linac (MRL). We present current workflows and practice standards from seven institutions for the initial patients treated for lymph node and liver metastases. |
format | Online Article Text |
id | pubmed-9108982 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-91089822022-05-17 First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac Janssen, Tomas M. Aitken, Katharine Alongi, Filippo Barry, Aisling Bernchou, Uffe Boeke, Simon Hall, William A. Hosni, Ali Kroon, Petra.S. Nachbar, Marcel Saeed, Hina Jürgenliemk-Schulz, Ina M. Schytte, Tine Verkooijen, Helena M. Nowee, Marlies.E. Tech Innov Patient Support Radiat Oncol Short communications and technical note The treatment of oligometastatic disease using MR guidance is an evolving field. Since August 2018 patients are treated on a 1.5 Tesla MR-Linac (MRL). We present current workflows and practice standards from seven institutions for the initial patients treated for lymph node and liver metastases. Elsevier 2022-05-10 /pmc/articles/PMC9108982/ /pubmed/35586786 http://dx.doi.org/10.1016/j.tipsro.2022.04.005 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Short communications and technical note Janssen, Tomas M. Aitken, Katharine Alongi, Filippo Barry, Aisling Bernchou, Uffe Boeke, Simon Hall, William A. Hosni, Ali Kroon, Petra.S. Nachbar, Marcel Saeed, Hina Jürgenliemk-Schulz, Ina M. Schytte, Tine Verkooijen, Helena M. Nowee, Marlies.E. First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac |
title | First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac |
title_full | First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac |
title_fullStr | First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac |
title_full_unstemmed | First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac |
title_short | First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac |
title_sort | first multicentre experience of sabr for lymph node and liver oligometastatic disease on the unity mr-linac |
topic | Short communications and technical note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108982/ https://www.ncbi.nlm.nih.gov/pubmed/35586786 http://dx.doi.org/10.1016/j.tipsro.2022.04.005 |
work_keys_str_mv | AT janssentomasm firstmulticentreexperienceofsabrforlymphnodeandliveroligometastaticdiseaseontheunitymrlinac AT aitkenkatharine firstmulticentreexperienceofsabrforlymphnodeandliveroligometastaticdiseaseontheunitymrlinac AT alongifilippo firstmulticentreexperienceofsabrforlymphnodeandliveroligometastaticdiseaseontheunitymrlinac AT barryaisling firstmulticentreexperienceofsabrforlymphnodeandliveroligometastaticdiseaseontheunitymrlinac AT bernchouuffe firstmulticentreexperienceofsabrforlymphnodeandliveroligometastaticdiseaseontheunitymrlinac AT boekesimon firstmulticentreexperienceofsabrforlymphnodeandliveroligometastaticdiseaseontheunitymrlinac AT hallwilliama firstmulticentreexperienceofsabrforlymphnodeandliveroligometastaticdiseaseontheunitymrlinac AT hosniali firstmulticentreexperienceofsabrforlymphnodeandliveroligometastaticdiseaseontheunitymrlinac AT kroonpetras firstmulticentreexperienceofsabrforlymphnodeandliveroligometastaticdiseaseontheunitymrlinac AT nachbarmarcel firstmulticentreexperienceofsabrforlymphnodeandliveroligometastaticdiseaseontheunitymrlinac AT saeedhina firstmulticentreexperienceofsabrforlymphnodeandliveroligometastaticdiseaseontheunitymrlinac AT jurgenliemkschulzinam firstmulticentreexperienceofsabrforlymphnodeandliveroligometastaticdiseaseontheunitymrlinac AT schyttetine firstmulticentreexperienceofsabrforlymphnodeandliveroligometastaticdiseaseontheunitymrlinac AT verkooijenhelenam firstmulticentreexperienceofsabrforlymphnodeandliveroligometastaticdiseaseontheunitymrlinac AT noweemarliese firstmulticentreexperienceofsabrforlymphnodeandliveroligometastaticdiseaseontheunitymrlinac AT firstmulticentreexperienceofsabrforlymphnodeandliveroligometastaticdiseaseontheunitymrlinac |